“Overview of SARS-Cov-2 and COVID-19 Vaccine” by Alharbil summarizes the information on vaccines developed against COVID-19. The author analyzes its main characteristics by framing the vaccine as a crucial tool to fight the disease. Despite some content limitations, the paper provides a valuable and efficient summary of the current status of immunization efforts against COVID-19.
Namely, the author starts the discussion by describing the origins and symptoms of the COVID-19 disease and then explains the inoculation development process and types. More importantly, the author provides an overview of the five prominent vaccines – BNT-162b2 (Pfizer), mRNA-1273 (Moderna), AZD-1222 (AstraZeneca), Ad26.COV2. S (Johnson & Johnson), NVX-CoV2373 (Novavax). The author classifies the vaccines according to their categories, including genetically encoded, viral vector, protein subunit, viral antibody types (Alharbil 512-513).
The author also includes logistical considerations such as transportation and storage into the summary (Alharbil 512-513). In addition, the paper presents an overview of the pharmaceutically-modified-non-injectable types of shots, emphasizing the major developers and the preliminary research results (Alharbil 514). Thus, the author effectively encapsulates the information about the current vaccines and those planned to be used.
In terms of evaluation, the paper indicates that there are no sponsorships or conflicts of interest involved. Hence, the credibility of the author and article can be considered high. Moreover, the author has a Doctorate level in Medicine and Medical Sciences, thus, has sufficient knowledge and authority. The major limitation of the paper is that the author fails to include the analysis of other prominent non-western vaccines. For instance, the Chinese vaccine Sinovac and the Russian vaccine (Gam-COVID-Vac-Lyo/Sputnik V) are widely distributed, and their efficacy rate was around 90% (Jones and Roy 643). Hence, adding information about these vaccines into the overview could have strengthened the paper.
Thus, this overview can help obtain a sufficient understanding of the prominent vaccines against COVID-19. Medical professionals, policymakers, and scholars can apply the information in this article to get basic information about COVID-19 vaccines. Although the author is reliable, they could extend the paper’s content by incorporating other prominent vaccines into the analysis.
Works Cited
Alharbil, Nada Abdullah. “Overview of SARS-Cov-2 and COVID-19 Vaccine”. Bahrain Medical Bulletin, vol. 43, no. 2, 2021, pp. 511-515. EBSCOhost. Web.
Jones, Ian, and Polly Roy. “Sputnik V COVID-19 Vaccine Candidate Appears Safe and Effective.” The Lancet, vol. 397, no. 10275, 2021, pp. 642–643. Web.